Deep Genomics
General contacts
Investor type
PE / VC
Founded
2014
AUM
$236 M
Location
Toronto, Ontario, Canada
Investor profile last updated: 13 October, 2025
Profile
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Industry
Deep Genomics Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Deep Genomics funding rounds
|
Venture Capital (VC)
|
Consumer Services (B2C)
Healthcare Services
AI
Technology
HealthTech
Machine Learning (ML)
|
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$236 M
|
November 2014
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Deep Genomics — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Deep Genomics
Is Deep Genomics a venture capital or private equity firm?
Deep Genomics is a venture capital and private equity firm. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Where is Deep Genomics located?
Deep Genomics is located in Toronto, Ontario, Canada.
When was Deep Genomics founded?
Deep Genomics was founded in 2014.
What sectors and industries does Deep Genomics invest in?
Deep Genomics invests in companies and startups in Healthcare Services, AI, Technology, HealthTech, Machine Learning (ML), Consumer Services (B2C).
What is Deep Genomics geographical focus of investments?
Deep Genomics invests in companies and startups in North America, Europe.
At what stages of companies and startups does Deep Genomics typically invest in?
Deep Genomics invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
What is the usual amount of Deep Genomics investment?
Deep Genomics usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for Deep Genomics?
Deep Genomics has around $236m assets under management.
When was Deep Genomics last fund created?
Deep Genomics last fund was created/launched in 2014-11-10
What are the contacts of Deep Genomics?
Deep Genomics can be reached through its website deepgenomics.com and its LinkedIn page. Its general enquiries address is press@deepgenomics.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Deep Genomics — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Deep Genomics data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Deep Genomics directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Deep Genomics profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 13 October, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.